Protective Effects of Crocin Against Beta-Amyloid Peptide-Induced CellApoptosis in PC۱۲ Cells Via the PI۳ K Pathway

Publish Year: 1402
نوع سند: مقاله کنفرانسی
زبان: English
View: 28

This Paper With 13 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

CONFMT06_004

تاریخ نمایه سازی: 31 اردیبهشت 1403

Abstract:

Background: Crocin is a known compound with the antioxidant and anti-inflammatory propertieswhich may help to reduce the progression of neurological disorders. In this study, we aimed toinvestigate the protective effects of crocin on beta-amyloid peptide Aβ (۱-۴۰) and hydrogen peroxide(H۲O۲) induced neurotoxicity in PC۱۲ cells.Methods: PC۱۲ cells were pretreated with crocin anddonepezil (۵ and ۱۰ μM) for ۲ h and then treated with Aβ (۱-۴۰) (۲۵ μM) for ۲۴ h. In parallel, afterpretreatment with crocin (۵ and ۱۰ μM) and donepezil (۵ and ۱۰ μM) for ۲۴ h, cells were treatedwith H۲O۲ (۸۰۰ μM) for ۴ h. Finally, the cell viability and intracellular reactive oxygen species(ROS) generation were evaluated using AlamarBlue® and ۲', ۷'-dichlorodihydrofluoresceindiacetate (DCFH-DA), respectively. The western blot test was done to compare the protein levelof phospho SAPK/JNK, SAPK/JNK, PI۳ Kinase P۸۵, Phospho-PI۳ Kinase P۸۵, caspase-۳ andcytochrome c) cyt c).Results: Crocin and donepezil could significantly decrease the Aβ toxicityand ROS level. While treatment with Aβ increased Cyt c release from mitochondria to cytosol,cleaved form of caspase-۳ (۱۷ kDa) and activated form of SAPK/JNK p۴۴/۴ decreased theactivated form of PI۳ Kinase P۸۵ protein, indicating that crocin could significantly block theapoptosis initiated with Aβ.Conclusion: According to the results, crocin could be a promisingcandidate for further evaluations against the development of Alzheimer's disease through mitogenactivatedprotein kinases (MAPK) and the phosphatidylinositol ۳-kinase (PI۳K)/protein kinase B(AKT) signaling (PI۳ K/AKT) pathways.

Authors

Reyhaneh Taheri

Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Elham Hadipour

Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University ofMedical Sciences, Mashhad, Iran

Zahra Tayarani-Najaran

Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University ofMedical Sciences, Mashhad, Iran